Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
2,029.85
-19.80 (-0.97%)
Feb 21, 2025, 3:29 PM IST
Caplin Point Laboratories Employees
Caplin Point Laboratories had 3,406 employees as of March 31, 2024. The number of employees increased by 1,764 or 107.43% compared to the previous year.
Employees
3,406
Change (1Y)
1,764
Growth (1Y)
107.43%
Revenue / Employee
5.55M INR
Profits / Employee
1.51M INR
Market Cap
154.31B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 3,406 | 1,764 | 107.43% |
Mar 31, 2023 | 1,642 | -1,358 | -45.27% |
Mar 31, 2022 | 3,000 | 1,325 | 79.10% |
Mar 31, 2021 | 1,675 | -21 | -1.24% |
Mar 31, 2020 | 1,696 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 9,741 |
Cipla | 27,764 |
Mankind Pharma | 19,540 |
Apollo Hospitals Enterprise | 83,147 |
Zydus Lifesciences | 26,921 |
Aurobindo Pharma | 26,015 |
Alkem Laboratories | 17,432 |
Caplin Point Laboratories News
- 16 days ago - Caplin Point Laboratories Q3 FY25 Results: Revenue up 13% YoY to Rs 493 crore, Net Profit up 17% YoY - Business Upturn
- 18 days ago - Caplin Point Laboratories subsidiary secures USFDA approval for Procainamide Hydrochloride Injection - Business Upturn
- 5 weeks ago - Caplin Point Laboratories subsidiary gets USFDA nod for Levetiracetam in sodium chloride injection - Business Upturn
- 6 weeks ago - Caplin Point receives zero 483 observation from USFDA in recent inspection - Business Upturn
- 2 months ago - Stock Market Update, December 27: Oberoi Realty, Caplin Point Laboratories and Jubilant FoodWorks hit 52-week highs today - Business Upturn
- 2 months ago - Caplin Point gets USFDA approval for eye drops – Difluprednate Ophthalmic Emulsion - Business Upturn
- 3 months ago - Caplin Point Laboratories shares hit new 52-week high this week; Check details - Business Upturn
- 3 months ago - Caplin Point Laboratories shares up 2% after strong Q2 performance - Business Upturn